Foghorn Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $285.9M
Liabilities Breakdown FY2023
Total Liabilities: $363.1M
Asset Breakdown
Total Assets: $285.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $80.3M | 28.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $205.6M | 71.9% |
Liabilities Breakdown
Total Liabilities: $363.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.3M | 1.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $356.8M | 98.3% |